As we can learn from the bees, a healthy social organism is characterized by close interaction of all members. Similarly, Health Care Providers, the Industry, Regulators, and Payers largely depend on each other. They all share the common goal of increasing benefit for patients.
However, developing meaningful innovations, generating tangible evidence, and finding the right price is often a highly challenging and controversial procedure.
r-connect aims to facilitate interaction between the various contributors to health care. We want to support our clients with the translation of their science into tangible value and finally into price.
Hot Topics
However, developing meaningful innovations, generating tangible evidence, and finding the right price is often a highly challenging and controversial procedure.
r-connect aims to facilitate interaction between the various contributors to health care. We want to support our clients with the translation of their science into tangible value and finally into price.
Hot Topics
- Acceptance of best-available evidence in benefit assessment of medicinal products: An analysis of procedures without availability of a randomized-controlled trial,
Gesundheitsökonomie & Qualitätsmanagement, March 2024
- Development and Pilot Test of the Registry Evaluation and Quality Standards Tool: An Information Technology–Based Tool to Support and Review Registries,
Value in Health, June 2022
- How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?,
Health Economics Review, June 2022
- Guidelines - their role in AMNOG and medical care,
Interdisciplinary Platform on Benefit Assessment, April 2022
 | Contact us for more information: info@r-connect.org |
